Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist

Dr. Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Department of Orthopedics, Zhongda Hospital, Southeast University School of Medicine | China

Dr. Zengxin Gao is a highly accomplished Chief Physician at Southeast University, Affiliated Zhongda Hospital, recognized for his expertise in orthopedics and minimally invasive spinal interventions. He completed his PhD in Orthopedics at Peking Union Medical College in 2008, following a Master’s degree in Orthopedics (2005) and a Bachelor’s degree in Clinical Medicine from Nanjing Medical University (1990). Dr. Zengxin Gao’s clinical career spans over 30 years, beginning as a physician at Nantong University Affiliated Dongtai Hospital, advancing to attending and associate chief physician, and currently serving as Chief Physician at Southeast University Affiliated Zhongda Hospital since 2015. His research focuses on spinal surgery, intervertebral disc regeneration, and innovative minimally invasive techniques for chronic low back and leg pain, particularly in elderly patients. He has led notable projects, including the Jiangsu Provincial Health Commission’s New Technology Introduction Project on percutaneous single-axis hole microscopy (2021–2023). Dr. Zengxin Gao has made significant scholarly contributions, including sole corresponding authorship in Wenbin Xuan, Yucheng Gao, Zengxin Gao. Intraspinal Bone Fragments Resorption in Thoracolumbar Burst Fracture. JAMA Neurol. 2023;80(11):1248–1249 [Cited 12]; co-first authorship in Linhui Ye, Zengxin Gao, Saeed Rohani. Intervertebral disk regeneration in a rat model by allopurinol-loaded Chitosan/alginate hydrogel. Biomol Biomed. 2023;23(4):661–670 [Cited 5]; and co-corresponding authorship in Shuhua Fang et al. Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskelet Disord. 2024;25:5 [Cited 3]. He has been awarded the Provincial and Ministerial First Prize for the Medical New Technology Introduction Award (2022) for pioneering percutaneous transforaminal endoscopic intervertebral fusion. Dr. Zengxin Gao’s combination of clinical expertise, innovative research, and leadership in orthopedics underscores his outstanding contributions and makes him an ideal candidate for the Innovative Research Award.

Profile: Scopus

Featured Publications

• Xuan, W., Gao, Y., & Gao, Z. (2023). Intraspinal bone fragments resorption in thoracolumbar burst fracture. JAMA Neurology, 80(11), 1248–1249.
https://doi.org/10.1001/jamaneurol.2023.2901

• Ye, L., Gao, Z., & Rohani, S. (2023). Intervertebral disk regeneration in a rat model by allopurinol-loaded chitosan/alginate hydrogel. Biomolecules and Biomedicine, 23(4), 661–670.
https://doi.org/10.17305/bjbms.2023.8535

• Fang, S., Cao, D., Wu, Z., Chen, J., Huang, Y., Shen, Y., & Gao, Z. (2024). Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskeletal Disorders, 25(1), 5.
https://doi.org/10.1186/s12891-023-07172-0

• Gao, Z., Lin, Y., Wu, Z., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2020). LncRNA SNHG6 can regulate the proliferation and apoptosis of rat degenerate nucleus pulposus cells via regulating the expression of miR-101-3p. European Review for Medical and Pharmacological Sciences, 24(16), 8251–8262.
https://doi.org/10.26355/eurrev_202008_22592

• Gao, Z., Lin, Y., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2019). Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo. American Journal of Translational Research, 11(9), 5956–5966.
https://www.ajtr.org/files/ajtr0094769.pdf

Alemayehu Toma | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Alemayehu Toma | Toxicology and Pharmaceutical Science | Best Researcher Award

Hawassa University College of Medicine and Health Sciences | Ethiopia

Dr. Alemayehu Toma is an Associate Professor of Pharmacology at Hawassa University, Ethiopia, and an accomplished researcher whose work bridges pharmacological science with public health impact. His professional career reflects an unwavering dedication to advancing medical knowledge, improving patient outcomes, and addressing pressing health challenges in both local and global contexts. Over his career, he has built an outstanding reputation for his research in HIV/AIDS treatment outcomes, pharmacovigilance, nutrition-related interventions, and the safety and efficacy of medicinal plants. With 45 peer-reviewed publications and more than 3,900 citations on Google Scholar, his research has significantly influenced both scientific literature and healthcare practice.

Professional Profile

Google Scholar

ORCID

Education

Dr. Toma’s academic path demonstrates a progressive commitment to mastery in pharmacology and medical science. He earned his Ph.D. in Pharmacology from Addis Ababa University, preceded by a Master’s degree in Pharmacology from the same institution, and a Bachelor of Pharmacy from Jimma University. To further enhance his educational contributions, he obtained a Higher Diploma in Pedagogy from Hawassa University, equipping him with the expertise to deliver effective teaching and mentorship in higher education. His academic background integrates deep pharmacological knowledge with practical clinical insight and refined pedagogical skill.

Experience

Dr. Toma’s professional career spans teaching, research, clinical service, and academic leadership. At Hawassa University, he held the role of Associate Professor of Pharmacology in the College of Medicine and Health Sciences, where he was also Head of the Quality Assurance Office. He played a pivotal role in maintaining academic standards, developing research capacity, and ensuring the quality of medical education. He has also served as an Assistant Professor of Pharmacology at Komar University of Science and Technology in Iraq, where he contributed to curriculum development and supervised postgraduate theses. His work as a licensed pharmacy specialist reflects his hands-on involvement in patient care, linking academic expertise with clinical practice.

Research Interest

Dr. Toma’s research interests are diverse but strongly interconnected, focusing on areas where pharmacological science directly impacts human health. His core areas include HIV/AIDS treatment outcomes and comorbidities, the effects of pharmacological interventions on organ systems, antidiabetic and antimicrobial activities of medicinal plants, nutritional status among vulnerable populations, and epidemiological studies of chronic and infectious diseases. He also contributes to multi-country global health collaborations, such as disease burden mapping, which inform policy and public health programs. His work is characterized by methodological rigor, translational relevance, and a commitment to addressing real-world medical challenges.

Awards and Recognition

Dr. Toma’s contributions to pharmacology and public health have been acknowledged in prestigious journals including The Lancet, BMJ Open, Scientific Reports, and BMC Infectious Diseases. His h-index of 19 is evidence of sustained research influence, while his work’s consistent citation by peers shows its enduring value. His collaborative publications with international research networks further underscore his role as a key contributor to global health science.

Publications

Title: Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Journal: The Lancet Respiratory Medicine
Published on: 2020
Citation: 2126

Title: Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the …
Journal: The Lancet HIV
Published on: 2019
Citation: 560

Title: Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease …
Journal: The Lancet
Published on: 2020
Citation: 152

Title: Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves
Journal: BMC Complementary and Alternative Medicine
Published on: 2014
Citation: 123

Title: Antidiabetic activities of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin-induced diabetic rats
Journal: BMC Complementary and Alternative Medicine
Published on: 2015
Citation: 121

Title: Phytochemistry and pharmacological activities of Moringa oleifera
Journal: International Journal of Pharmacognosy
Published on: 2014
Citation: 94

Title: Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of …
Journal: Occupational and Environmental Medicine
Published on: 2020
Citation: 76

Title: Antimicrobial resistance profile of Staphylococcus aureus isolates isolated from ear discharges of patients at University of Hawassa comprehensive specialized …
Journal: BMC Pharmacology and Toxicology
Published on: 2017
Citation: 74

Conclusion

Dr. Alemayehu Toma’s career stands as a model of academic excellence, research productivity, and societal impact. His studies have provided crucial insights into the management of HIV/AIDS, nutrition in vulnerable groups, medicinal plant pharmacology, and the global burden of diseases. He has consistently demonstrated the ability to translate research findings into actionable recommendations for health systems, contributing to policy change and improved clinical outcomes. His leadership in academia, commitment to mentoring emerging scholars, and active collaboration in international research initiatives make him an outstanding candidate for the Best Researcher Award. This recognition would not only honor his past achievements but also encourage further contributions that can transform healthcare practice in resource-limited settings worldwide.